Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Alnylam Pharmaceuticals, Inc.    ALNY   US02043Q1076

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/18/2015 05/19/2015 05/20/2015 05/21/2015 05/22/2015 Date
121.62(c) 117.33(c) 123.95(c) 124.88(c) 124.81(c) Last
715 054 679 041 1 115 638 589 139 377 923 Volume
+1.49% -3.53% +5.64% +0.75% -0.06% Change
More quotes
Financials ($)
Sales 2015 56,7 M
EBIT 2015 -247 M
Net income 2015 -242 M
Finance 2015 635 M
Yield 2015 -
Sales 2016 56,0 M
EBIT 2016 -275 M
Net income 2016 -278 M
Finance 2016 431 M
Yield 2016 -
PER 2015 -
PER 2016
EV / Sales 2015 174x
EV / Sales 2016 180x
Capitalization 10 519 M
More Financials
Company
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which develops novel therapeutics based on RNA interference.It is leading the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases, including... 
More about the company
Surperformance© ratings of Alnylam Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
Latest news on ALNYLAM PHARMACEUTICALS, I
05/20 ALNYLAM PHARMACEUTICALS : Receives Orphan Drug Designation from the United State..
05/17 ALNYLAM PHARMACEUTICALS : Files Clinical Trial Application (CTA) for ALN-AAT, an..
05/14 ALNYLAM PHARMACEUTICALS : Reports First Quarter 2015 Financial Results and Highl..
05/12 Alnylam Pharmaceuticals Reports First Quarter 2015 Financial Results and High..
05/07 ALNYLAM PHARMACEUTICALS : reports 1Q loss
05/07 ALNYLAM PHARMACEUTICALS : Results of Operations and Financial Condition, Financi..
05/07 ALNYLAM PHARMACEUTICALS : Reports First Quarter 2015 Financial Results and Highl..
05/05 ALNYLAM PHARMACEUTICALS : Submission of Matters to a Vote of Security Holders (f..
More news
Sector news : Biotechnology & Medical Research - NEC
05/24 QUINTILES TRANSNATIONAL : Launches New Solution to Meet Needs of Asia-Pacific Em..
05/22 SYNAGEVA BIOPHARMA : SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investiga..
05/22 BLUEBIRD BIO : Announces Participation at the Jefferies 2015 Global Healthcare C..
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
05/20 Alnylam's revusiran an Orphan Drug for amyloidosis
05/15 After Hours Gainers / Losers
05/08 Alnylam Pharma revenues up 123% in Q1
05/07 Alnylam Pharmaceuticals (ALNY) Q1 2015 Results - Earnings Call Webcast
05/07 OVASCIENCE : Reproducible Results


Comments 
Advertisement
Chart ALNYLAM PHARMACEUTICALS, I
Duration : Period :
Alnylam Pharmaceuticals, I Technical Analysis Chart | ALNY | US02043Q1076 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions